Article

Burden of disease and barriers to the diagnosis and treatment of group a beta-hemolytic streptococcal pharyngitis for the prevention of rheumatic heart disease in Dar Es Salaam, Tanzania.

Harvard Medical School, Cannon Society, Boston, MA 02115, USA.
The Pediatric Infectious Disease Journal (Impact Factor: 3.14). 12/2010; 29(12):1135-7. DOI: 10.1097/INF.0b013e3181edf475
Source: PubMed

ABSTRACT To understand patient and clinician attitudes toward Streptococcus pharyngitis and rheumatic heart disease prevention in Tanzania, data from 3 sources were obtained: a survey of 119 clinicians, outpatient rapid test screening, and interviews with 17 rheumatic heart disease patients. Patients do not seek care for sore throat. Clinicians stated that identifying and treating Streptococcus pharyngitis is not prioritized.

1 Follower
 · 
37 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Group A streptococcus (GAS) and possibly other β-hemolytic streptococci (BHS) account for a considerable morbidity and mortality burden in African populations; however, disproportionately little is known about the epidemiology of BHS in sub-Saharan Africa. This study assessed the prevalence of GAS, group G streptococcus (GGS) and group C streptococcus (GCS) carriage and tonsillopharyngitis in a Central African population. A prospective cross-sectional study was performed to assess the prevalence of and risk factors for BHS carrier status and tonsillopharyngitis in children and adults in Gabon. The overall BHS carrier prevalence was 135/1,005 (13.4 %); carrier prevalence of GAS, GGS, and GCS was 58/1,005 (5.8 %), 50/1,005 (5.0 %), and 32/1,005 (3.2 %), respectively. Streptococcal carriage was associated with school and pre-school age (adjusted OR 2.65, 95 % CI 1.62-4.36, p = 0.0001 and 1.90, 95 % CI 1.14-3.17, p = 0.0141, respectively). Participants residing in urban areas were less likely carriers (OR 0.52, p = 0.0001). The point-prevalence of BHS-positive tonsillopharyngitis was 1.0 % (9/1,014) and 15.0 % (6/40) in school children with sore throat. Non-GAS exceeded GAS throat carriage and tonsillopharyngitis suggesting a yet underestimated role of non-GAS streptococci in BHS diseases.
    Infection 11/2014; 43(2). DOI:10.1007/s15010-014-0709-y · 2.86 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In Kenya, > 10 million episodes of acute febrile illness are treated annually among children under 5 years. Most are clinically managed as malaria without parasitological confirmation. There is an unmet need to describe pathogen-specific etiologies of fever. We enrolled 370 febrile children and 184 healthy controls. We report demographic and clinical characteristics of patients with Plasmodium falciparum, group A streptococcal (GAS) pharyngitis, and respiratory viruses (influenza A and B, respiratory syncytial virus [RSV], parainfluenza [PIV] types 1-3, adenovirus, human metapneumovirus [hMPV]), as well as those with undifferentiated fever. Of febrile children, 79.7% were treated for malaria. However, P. falciparum was detected infrequently in both cases and controls (14/268 [5.2%] versus 3/133 [2.3%], P = 0.165), whereas 41% (117/282) febrile children had a respiratory viral infection, compared with 24.8% (29/117) controls (P = 0.002). Only 9/515(1.7%) children had streptococcal infection. Of febrile children, 22/269 (8.2%) were infected with > 1 pathogen, and 102/275(37.1%) had fevers of unknown etiology. Respiratory viruses were common in both groups, but only influenza or parainfluenza was more likely to be associated with symptomatic disease (attributable fraction [AF] 67.5% and 59%, respectively). Malaria was overdiagnosed and overtreated. Few children presented to the hospital with GAS pharyngitis. An enhanced understanding of carriage of common pathogens, improved diagnostic capacity, and better-informed clinical algorithms for febrile illness are needed. ©The American Society of Tropical Medicine and Hygiene.
    The American journal of tropical medicine and hygiene 03/2015; 92(5). DOI:10.4269/ajtmh.14-0560 · 2.74 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Acute rheumatic fever and rheumatic heart disease are diseases of poverty, low socioeconomic status, and inadequate access to health care. These preventable diseases remain largely ignored by the developed world while they continue to cause significant mortality and morbidity in the developing world. In the face of no existing cure, we need to focus on prevention and control methods. To this end, creating awareness of the disease and its effects on millions of people in the world is critically important. In this review, we will outline the importance of these efforts, discuss the barriers to awareness and education, and highlight some important models in this arena. We strongly support awareness-raising and health promotion strategies as an integral part of a rheumatic heart disease prevention and control program. Copyright © 2013. Published by Elsevier B.V.
    09/2013; 8(3):235–239. DOI:10.1016/j.gheart.2013.08.009